Fecal calprotectin in children with the enthesitis-related arthritis subtype of juvenile idiopathic arthritis

Journal of Rheumatology

Volumn 38, Issue 10, 2011, Pages 2274-2275

  Stoll, Matthew L ^a,b   Punaro, Marilynn ^a,b   Patel, Ashish S ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b TEXAS SCOTTISH RITE HOSPITAL FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALGRANULIN; CORTICOSTEROID; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; HLA B27 ANTIGEN; HYDROXYCHLOROQUINE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT;

ABDOMINAL PAIN; ARTHRALGIA; ARTHRITIS; CHILD; CLINICAL ARTICLE; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DERMATOMYOSITIS; DIARRHEA; DISEASE ACTIVITY; ENTHESITIS; ENTHESITIS RELATED ARTHRITIS; FECES ANALYSIS; FEMALE; GASTROINTESTINAL SYMPTOM; HEMATOCHEZIA; HUMAN; IRIDOCYCLITIS; JOINT HYPERMOBILITY; JUVENILE RHEUMATOID ARTHRITIS; LETTER; LOOSE FECES; MALE; MICROSCOPIC POLYANGIITIS; PRESCHOOL CHILD; PRIORITY JOURNAL; SACROILIITIS; SCHOOL CHILD; SCLERODERMA; SPONDYLOARTHROPATHY; STUNTING; WEIGHT REDUCTION;

ADOLESCENT; ARTHRITIS, JUVENILE RHEUMATOID; CHILD; CHILD, PRESCHOOL; FECES; FEMALE; GASTROINTESTINAL TRACT; HUMANS; INFLAMMATION; LEUKOCYTE L1 ANTIGEN COMPLEX; MALE;

EID: 80053521383     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.110508     Document Type: Letter

References (10)

1. Mielants H, Veys EM, Goemaere S, Goethals K, Cuvelier C, De Vos M. Gut inflammation in the spondyloarthropathies: clinical, radiologic, biologic and genetic features in relation to the type of histology. A prospective study. J Rheumatol 1991;18:1542-51.
2. Mielants H, Veys EM, Cuvelier C, De Vos M, Goemaere S, Maertens M, et al. Gut inflammation in children with late onset pauciarticular juvenile chronic arthritis and evolution to adult spondyloarthropathy - a prospective study. J Rheumatol 1993;20:1567-72. (Pubitemid 24027334)
3. Mielants H, Veys EM, Cuvelier C, De Vos M, Goemaere S, De Clercq L, et al. The evolution of spondyloarthropathies in relation to gut histology. III. Relation between gut and joint. J Rheumatol 1995;22:2279-84.
4. Sinha R, Nwokolo C, Murphy PD. Magnetic resonance imaging in Crohn's disease. BMJ 2008;336:273-6. (Pubitemid 351251630)
5. De Vries M, van der Horst-Bruinsma I, van Hoogstraten I, van Bodegraven A, Von Blomberg BM, Ratnawati H, et al. pANCA, ASCA, and OmpC antibodies in patients with ankylosing spondylitis without inflammatory bowel disease. J Rheumatol 2010;37:2340-4.
6. Costa F, Mumolo MG, Bellini M, Romano MR, Ceccarelli L, Arpe P, et al. Role of faecal calprotectin as non-invasive marker of intestinal inflammation. Dig Liver Dis 2003;35:642-7. (Pubitemid 41110875)
7. Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004;31:390-2. (Pubitemid 38160763)
8. Wyllie R, Hyams JS, Kay M, editors. Pediatric gastrointestinal and liver diseases. 3rd ed. London: Elsevier; 2006.
9. Bunn SK, Bisset WM, Main MJ, Golden BE. Fecal calprotectin as a measure of disease activity in childhood inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2001;32:171-7. (Pubitemid 32280632)
10. Tibble JA, Sigthorsson G, Foster R, Scott D, Fagerhol MK, Roseth A, et al. High prevalence of NSAID enteropathy as shown by a simple faecal test. Gut 1999;45:362-6. (Pubitemid 29400711)